Insulin lispro (Humalog), a novel fast-acting insulin analogue: guidelines for its practical use.
Nobels
F R
FR
Onze-Lieve-Vrouwziekenhuis, Cliniques Universitaires, U.C.L. St. Luc, Brussel. frank.nobels@olvz-aalst.be
Hermans
M P
MP
De Leeuw
I
I
D001786:Blood Glucose / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007328:Insulin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D061268:Insulin Lispro; D010353:Patient Education as Topic; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D012307:Risk Factors
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D061268:Insulin Lispro